The DOI matches its Crossref record.
The value of serum carcinoembryonic antigen in predicting recurrent disease following curative resection of colorectal cancer
Abstract
UNLABELLED: Carcinoembryonic antigen (CEA) estimations are used to facilitate early diagnosis of recurrent disease after treatment for colorectal cancer. PURPOSE: This study was designed to determine the natural history of patients with normal and abnormal levels of CEA. METHODS: Patients undergoing potential curative resection of colorectal tumors (Dukes Stage A-C) entered a prospective, randomized trial comparing two follow-up regimens (to be reported separately) had CEA levels measured every 3 months for two years; then every 6 months for the next three years. In the study protocol, a rise in CEA was not an indication for investigation to determine recurrence unless there was also other evidence of recurrent disease. RESULTS: Three hundred eleven patients were followed for a median of 4.5 (range, 2-5) years. Recurrent disease developed in 98 (32 percent) patients, 57 of whom had an elevated CEA (sensitivity 58 percent), with a median lead time of six (range, 1-30) months from first abnormal CEA to diagnosis of recurrent disease by other means. The specificity, positive predictive value, and negative predictive value of CEA as an indicator of subsequent recurrent disease was 93 percent, 79 percent, and 83 percent, respectively. The sensitivity of CEA for predicting hepatic metastases was 80 percent, with a median lead time of eight (range, 1-30) months, compared with only 46 percent for sites of recurrent disease other than the liver. CONCLUSIONS: CEA was the first indicator of recurrent disease in 58 percent of all patients and in 80 percent of patients with liver metastases. The diagnosis of recurrent disease may be made several months earlier by investigating the first abnormal CEA level, although any benefit in terms of survival remains to be proven.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Renehan, A. G., Egger, M., Saunders, M. P., & O'Dwyer, S. T. (2002) · BMJ · doi:10.1136/bmj.324.7341.813 · Cited by 651
Carcinoembryonic Antigen in the Staging and Follow-up of Patients with Colorectal Cancer
Goldstein, M. J., & Mitchell, E. P. (2005) · Cancer Investigation · doi:10.1081/cnv-58878 · Cited by 419
Guidelines for resection of colorectal cancer liver metastases
Garden, O. J. (2006) · Gut · doi:10.1136/gut.2006.098053 · Cited by 417
Schoemaker, D., Black, R., Giles, L., & Toouli, J. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70626-2 · Cited by 386
Self-citationFollow-up strategies for patients treated for non-metastatic colorectal cancer
Jeffery, M., Hickey, B. E., & Hider, P. N. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002200.pub2 · Cited by 205
Surveillance after colorectal cancer resection
Berman, J. M., Cheung, R. J., & Weinberg, D. S. (2000) · The Lancet · doi:10.1016/s0140-6736(99)06552-6 · Cited by 124
Metadata
- Authors
- McCall, J. L., Black, R. B., Rich, C. A., Harvey, J. R., Baker, R. A., Watts, J. M., & Toouli, J.
- Venue
- Diseases of the Colon & Rectum
- Published
- 1994-09
- Volume
- 37
- Issue
- 9
- Pages
- 875-881
- ISSN
- 0012-3706 (ISSN-L)
- OpenAlex
- W2793925659
- Cited by
- 166
- References
- 0
- FWCI
- 2.39
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.